What do AMH and FSH actually measure?
AMH is produced by granulosa cells in small developing follicles. The more small follicles present, the higher the AMH level. As the pool of remaining follicles decreases with age or other factors, AMH falls. AMH is the most widely used marker of ovarian reserve because it is relatively stable across the menstrual cycle and reflects the total antral follicle pool.
FSH is produced by the pituitary gland and drives follicle development each cycle. When the ovarian reserve is robust, the ovaries respond easily to FSH and the pituitary does not need to produce large amounts. When reserve declines, the ovaries become less responsive, and the pituitary increases FSH output in an attempt to stimulate adequate follicle development. Elevated FSH reflects this compensatory overstimulation.
What AMH and FSH do not measure:
- The chromosomal integrity of the remaining eggs
- The mitochondrial energy capacity of developing oocytes
- The oxidative stress level in follicular fluid
- The hormonal and nutritional adequacy of the follicular environment
- The probability of conception in the next cycle
A 2019 review in the Journal of Clinical Endocrinology and Metabolism found that AMH and FSH were reliable predictors of ovarian response to stimulation in IVF but were not reliable predictors of live birth rate per cycle in women of the same age, confirming that reserve quantity does not determine conception outcome.
What is the actual relationship between AMH, FSH, and my odds of conceiving?
The relationship between AMH, FSH, and conception probability is more nuanced than most women with a DOR diagnosis are told. Reserve markers predict how many eggs can be retrieved in an IVF cycle and how many cycles may be available before reserve is exhausted. They do not predict whether the eggs available in any given cycle will be chromosomally normal, will fertilize, or will produce a viable pregnancy.
What the research actually shows:
- A large prospective study published in the Journal of the American Medical Association found no significant association between AMH level and time to pregnancy in women trying to conceive naturally under age 40, after controlling for age. This is a striking finding that contradicts the intuitive assumption that lower AMH means lower conception probability.
- In IVF, low AMH predicts fewer eggs retrieved per cycle, which reduces the number of attempts available before reserve is depleted. It does not reduce the quality of the eggs retrieved or the probability that any individual egg will be chromosomally normal for a woman of her age.
- FSH variability matters: FSH above 15 mIU/mL measured on one cycle day 3 does not permanently define reserve. FSH can return to a lower value in subsequent cycles. Many reproductive endocrinologists consider the lowest FSH value across two to three consecutive tests more clinically relevant than any single elevated reading.
The practical implication is that a woman with low AMH and elevated FSH has fewer eggs remaining, which creates real time pressure. It does not mean her remaining eggs are non-viable, and it does not make the quality factors that determine whether those eggs produce healthy pregnancies irrelevant.
Can AMH and FSH values change over time?
AMH naturally declines with age as the follicular pool diminishes, and this decline is not reversible in a fundamental biological sense. However, AMH values can fluctuate meaningfully across cycles in the same woman, and specific physiological conditions can suppress AMH temporarily below its true baseline.
Factors that can temporarily lower AMH readings:
- Vitamin D deficiency: vitamin D insufficiency is associated with reduced AMH values in research studies. Correcting vitamin D deficiency has been shown to produce modest increases in AMH in some women, suggesting that low vitamin D was suppressing a value that reflects more reserve than the low reading indicated.
- Recent oral contraceptive use: hormonal contraceptives suppress follicle development and AMH for weeks to months after discontinuation. AMH tested within three to six months of stopping oral contraceptives may read lower than the true non-suppressed baseline.
- Significant physiological stress: acute illness, extreme training loads, or recent surgery can temporarily reduce AMH values. Testing during or shortly after such events may not reflect baseline reserve.
- Normal cycle-to-cycle variation: AMH varies by up to 15 to 20 percent across cycles in the same woman under stable conditions. A single low reading should be confirmed with a second test before major treatment decisions are made.
FSH variation is even more pronounced. FSH measured on cycle day 3 can differ by 5 to 10 mIU/mL between cycles in the same woman, influenced by stress, sleep, illness, and cycle characteristics. An elevated FSH reading warrants confirmation rather than immediate treatment escalation.
A 2021 review in Human Reproduction found that serial AMH testing over two to three cycles produced a more reliable estimate of true ovarian reserve than any single measurement, and that single-cycle AMH misclassified reserve level in approximately 20 percent of women tested.
What does diminished ovarian reserve mean for IVF specifically?
In the context of IVF, diminished ovarian reserve means that fewer eggs are likely to be retrieved per stimulation cycle, which has two practical consequences: fewer embryos available for selection and transfer, and fewer retrieval cycles possible before reserve is depleted. These are real clinical constraints that affect treatment planning.
How DOR changes the IVF picture:
- Lower egg numbers per retrieval: women with AMH below 1.0 ng/mL typically retrieve fewer than 5 eggs per cycle with standard stimulation protocols. Some retrieve only 1 to 3. Each egg retrieved has the same per-egg probability of being chromosomally normal for a woman of that age, but fewer eggs means fewer chances to find a normal one in any given cycle.
- Modified stimulation protocols: women with DOR often respond better to mini-IVF or natural cycle IVF protocols than to high-dose conventional stimulation. The optimal protocol depends on individual response and should be discussed with a reproductive endocrinologist who specializes in poor responders.
- Egg banking across multiple cycles: some women with low AMH bank eggs or embryos from multiple low-yield retrievals before proceeding to transfer, increasing the total number of embryos available for genetic testing and selection.
- Timing urgency: the most clinically meaningful implication of low AMH is that the number of available retrieval cycles is more limited than in women with normal reserve. This creates real time pressure to make informed decisions about how to use each cycle.
Research published in Reproductive BioMedicine Online found that women with low AMH who underwent egg quality optimization before IVF retrieved similar or improved embryo quality per egg compared to their prior cycles, confirming that the per-egg quality picture is addressable even when quantity is limited.
What should I do if I have low AMH and high FSH?
The most productive response to a low AMH and high FSH result combines realistic acknowledgment of the quantity picture with directed investigation of the quality factors that remain within your influence. Treating reserve markers as a verdict without examining the quality picture is a common and consequential error.
Recommended next steps:
- Confirm the numbers with serial testing: request AMH and FSH retesting in the next one to two cycles before making major treatment decisions. If vitamin D has not been tested, add it to the panel, as deficiency may be artificially suppressing AMH.
- Add antral follicle count: AMH and FSH provide a hormonal view of reserve; transvaginal ultrasound antral follicle count provides a direct anatomical count of visible small follicles. The two together give a more complete reserve picture than either alone.
- Investigate egg quality factors independently of reserve markers: request mid-luteal progesterone, thyroid panel with antibodies, hs-CRP, and fasting insulin. These quality-relevant markers are not captured by AMH or FSH and are addressable regardless of reserve level.
- Discuss protocol options with a poor-responder specialist: if your current RE uses a one-size-fits-all stimulation protocol, requesting a referral to or second opinion from a specialist in poor responders may open protocol options better suited to your specific picture.
- Begin a 90-day egg quality protocol: with limited reserve, each egg that reaches retrieval matters more, not less. Maximizing the quality of the eggs available is arguably more important in low-reserve women than in high-reserve women for exactly this reason.
According to the European Society of Human Reproduction and Embryology, personalized stimulation protocol selection based on ovarian reserve markers and antral follicle count is standard of care for women with diminished ovarian reserve, and outcomes vary significantly by protocol choice.
The The Fertility Intelligence Hub Perspective
Low AMH is not a sentence. It is a data point that tells you to move with intention.
I remember exactly how it felt to receive a low AMH result. The way the number was delivered felt like a door closing. Like the conversation was already heading toward a conclusion before I had a chance to ask a question.
What I know now is that the number told me something real and something limited at the same time. It told me there were fewer eggs remaining than average. It told me nothing about the quality of those eggs, about whether the eggs I had were being given the best possible environment to mature in, or about whether the physiological contributors affecting my fertility had been investigated at all.
Low AMH means less time to work with. It does not mean the work is not worth doing. In some ways, it means the work matters more, because each cycle counts more when cycles are limited.
Fertility Block Mapping in the context of low AMH focuses on exactly this: understanding the quality picture that reserve markers do not capture, and directing the available time and resources toward the most leveraged interventions. The number tells you how many chances you have. The quality work is about making each chance as strong as possible.
